E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Cisplatin treatment in pulmonary sarcoidosis: An In silico approach

Tuba Denkçeken, Elif Pala, Necla Benlier.

Abstract
Background: Sarcoidosis is a complex disorder characterized by parenchymal lung involvement, intrathoracic lymphadenopathy, and extrapulmonary manifestations. Sarcoidosis can cause high mortality and morbidity.

Aims and Objectives: It is needed computational methods to estimate potential miRNA-disease-drug relationships in pulmonary sarcoidosis since experimental approaches are expensive and time consuming.

Materials and Methods: In this study, we performed principal component analysis -based unsupervised feature extraction method to GSE34608 microRNA expression profile, which was downloaded from the Gene Expression Omnibus database that consists of peripheral blood samples of eight pulmonary sarcoidosis patients and eight healthy controls.

Results: We detected a set of 100 microRNAs that could successfully discriminate pulmonary sarcoidosis patients from healthy controls with 81.2% accuracy. Among these miRNAs, we validated miR-15b by Human MicroRNA Disease Database and identified 22 pathways by miRpath and 20 approved drugs by PharmacomiR. When these pathways were integrated with drug-affected pathways detected by the database for annotation, visualization, and integrated discovery database, four overlapping pathways were determined, which were closely associated with cisplatin.

Conclusion: This study provides novel insight into pulmonary sarcoidosis pathogenesis, and we identified potential drug candidate for this disease.

Key words: Pulmonary Sarcoidosis; microRNA; Principal Component Analysis -based Unsupervised Feature Extraction; Cisplatin


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Tuba Denkçeken
Articles by Elif Pala
Articles by Necla Benlier
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Denkceken T, Pala E, Benlier N. Cisplatin treatment in pulmonary sarcoidosis: An In silico approach. Natl J Physiol Pharm Pharmacol. 2020; 10(10): 900-904. doi:10.5455/njppp.2020.10.07193202024072020


Web Style

Denkceken T, Pala E, Benlier N. Cisplatin treatment in pulmonary sarcoidosis: An In silico approach. http://www.njppp.com/?mno=106349 [Access: October 01, 2020]. doi:10.5455/njppp.2020.10.07193202024072020


AMA (American Medical Association) Style

Denkceken T, Pala E, Benlier N. Cisplatin treatment in pulmonary sarcoidosis: An In silico approach. Natl J Physiol Pharm Pharmacol. 2020; 10(10): 900-904. doi:10.5455/njppp.2020.10.07193202024072020



Vancouver/ICMJE Style

Denkceken T, Pala E, Benlier N. Cisplatin treatment in pulmonary sarcoidosis: An In silico approach. Natl J Physiol Pharm Pharmacol. (2020), [cited October 01, 2020]; 10(10): 900-904. doi:10.5455/njppp.2020.10.07193202024072020



Harvard Style

Denkceken, T., Pala, . E. & Benlier, . N. (2020) Cisplatin treatment in pulmonary sarcoidosis: An In silico approach. Natl J Physiol Pharm Pharmacol, 10 (10), 900-904. doi:10.5455/njppp.2020.10.07193202024072020



Turabian Style

Denkceken, Tuba, Elif Pala, and Necla Benlier. 2020. Cisplatin treatment in pulmonary sarcoidosis: An In silico approach. National Journal of Physiology, Pharmacy and Pharmacology, 10 (10), 900-904. doi:10.5455/njppp.2020.10.07193202024072020



Chicago Style

Denkceken, Tuba, Elif Pala, and Necla Benlier. "Cisplatin treatment in pulmonary sarcoidosis: An In silico approach." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 900-904. doi:10.5455/njppp.2020.10.07193202024072020



MLA (The Modern Language Association) Style

Denkceken, Tuba, Elif Pala, and Necla Benlier. "Cisplatin treatment in pulmonary sarcoidosis: An In silico approach." National Journal of Physiology, Pharmacy and Pharmacology 10.10 (2020), 900-904. Print. doi:10.5455/njppp.2020.10.07193202024072020



APA (American Psychological Association) Style

Denkceken, T., Pala, . E. & Benlier, . N. (2020) Cisplatin treatment in pulmonary sarcoidosis: An In silico approach. National Journal of Physiology, Pharmacy and Pharmacology, 10 (10), 900-904. doi:10.5455/njppp.2020.10.07193202024072020